Houston Methodist is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This website uses cookies to improve website functionality and performance, to analyze website traffic, and to provide you with a more personalized experience. To find out more about the cookies we use, see our Digital Privacy Policy, Disclaimer & Terms of Use.

Search for tag: "tocilizumab"

1 Media

Houston Methodist Cancer Symposium - 8th Annual… duration 17 minutes 20 seconds Houston Methodist Cancer Symposium - 8th Annual… Houston Methodist Cancer Symposium - 8th Annual 08.07.20 (Andrew Chung, MD/PhD Candidate)	Houston Methodist Cancer Symposium - 8th Annual 08.07.20 (Andrew Chung, MD/PhD Candidate) Evaluating efficacy of tocilizumab for a subtype of triple negative Breast cancer that resists Chemotherapy via an autocrine IL-1A mediated self-induction of IL-6 cancer symposium +7 More From CME Admins 0 likes 82 plays

Houston Methodist Cancer Symposium - 8th Annual…

duration 17 minutes 20 seconds

Houston Methodist Cancer Symposium - 8th Annual…

Houston Methodist Cancer Symposium - 8th Annual 08.07.20 (Andrew Chung, MD/PhD Candidate)

Evaluating efficacy of tocilizumab for a subtype of triple negative Breast cancer that resists Chemotherapy via an autocrine IL-1A mediated self-induction of IL-6

cancer symposium

+7 More

From CME Admins 0 likes 82 plays